
    
      A prospective, single-arm, non-blinded study, intending to collect and evaluate data in up to
      forty (40) human subjects with acute thrombosis, treated with the CAPEREâ„¢ Thrombectomy
      System.

      Subjects will be evaluated based on VEINES QoL survey pre- and post-treatment (30-days).
    
  